Acute hypoxia and reoxygenation impairs exhaled nitric oxide release and pulmonary mechanics  by Pearl, Jeffrey M. et al.
R ecent evidence suggests that measurement ofexhaled nitric oxide (NO) might serve as a marker
of altered pulmonary function. Elevated levels of
exhaled NO have been demonstrated in chronic
bronchial asthma,1-3 whereas decreased levels have
been found in more acute conditions, such as acute res-
piratory distress syndrome and congestive heart fail-
ure.4,5 Altered levels of exhaled NO have also been
found in smokers compared with nonsmokers, suggest-
ing that bronchial epithelial injury can affect exhaled
NO levels. Similarly, acute lung injury, such as that
occurring during reoxygenation after hypoxia, might
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ACUTE HYPOXIA AND REOXYGENATION IMPAIRS EXHALED NITRIC OXIDE RELEASE
AND PULMONARY MECHANICS
also affect exhaled NO. The relationship between
exhaled NO and vascular-derived NO, estimated by
plasma nitrite and nitrate levels, is unclear. Evidence
suggests that a significant amount of exhaled NO is
derived from the bronchial epithelium rather than orig-
inating from NO in the vascular compartment.
Furthermore, the presence of nitric oxide synthase
(NOS) II in the bronchial epithelium confirms a poten-
tial distinct source of NO production outside the vascu-
lar compartment.6
With the identification of NOS II in the bronchial
epithelium and the advent of technology to measure
exhaled NO interest arose in the role of exhaled NO
during homeostatic, as well as pathologic conditions.
Specifically, it was hypothesized that changes in
exhaled NO levels in conditions associated with altered
pulmonary mechanics and gas exchange might be a
direct result of restricted bronchial epithelial function
and NOS activity. Our model of acute hypoxia with
reoxygenation resulted in acute lung injury.7 We
hypothesized that exhaled NO might serve as a marker
for lung injury in our model and furthermore that
exhaled NO does not correlate with plasma nitrite lev-
els. We reasoned that changes in exhaled NO were
associated with altered pulmonary mechanics seen dur-
ing hypoxia-reoxygenation. This study investigated
these hypotheses by using an established neonatal
piglet model of hypoxia and reoxygenation.
Materials and methods
Neonatal 2-week-old piglets weighing 4 to 6 kg were used
in this study. Animals received humane care in compliance
with the “Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research and the “Guide
for the Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources and published by
the National Institutes of Health (National Institutes of Health
publication No. 85-23, revised 1985).
An established model of hypoxia-reoxygenation from our
laboratory was used.7 The piglets were anesthetized with ke-
tamine, intubated with a cuffed endotracheal tube, and
mechanically ventilated by using a volume-controled ventila-
tor (Siemens 900B; Siemens-Elema, Solna, Sweden). A con-
stant inhaled tidal volume of 18 mL/kg was maintained with
an initial fraction of inspired oxygen (FIO2) of 40%. Femoral
arterial and venous lines were placed. Deep sedation and
paralysis were maintained by an infusion of nembutal (20 mg
· kg–1 · h–1), intermittent fentanyl (10 µg · kg–1 · h–1), and pan-
curonium (0.2 mg · kg–1 · h–1). Arterial blood gasses were
measured, and co-oximetry was performed every 15 minutes
(Chiron Diagnostics Co, East Walpole, Mass).
Transducer-tipped catheters (Millar Instruments Inc,
Houston, Tex) were placed in the pulmonary artery and in the
right and left ventricles for measuring right ventricular end-
diastolic pressure and left ventricular end-diastolic pressure.
A Doppler flow probe placed around the pulmonary arterial
trunk (T206; Transonic Systems, Inc, Ithaca, NY) was used to
monitor cardiac output.
The alveolar PO2 at an FIO2 of 40% was calculated by the
alveolar gas equation to allow determination of alveolar-arte-
rial gradient. Dynamic airway compliance (Cdyn) and inspi-
ratory airway resistance (RaW) were measured by using the
CO2SMO Plus Respiratory Profile Monitor (Novametrix
Medical Systems, Inc, Wallingford, Conn). Inspiratory tidal
volume was kept constant, and measurements from 10 con-
secutive breaths were averaged to determine RaW and Cdyn.
Exhaled NO was measured by a Sievers chemilumines-
cence NO monitor (NOA 270B; Sievers Medical Instruments
Inc, Boulder, Colo). Exhaled NO was measured throughout
the exhalation cycle with both a peak and a mean value
determined by the NOA software (Breath-By-Breath Exhaled
NO Software, Version 2.11, Sievers Instruments, Inc).
Chemiluminescence NO measurement involved an electrical
signal proportional to the light generated from a reaction
between NO and ozone. Other laboratories have validated
this technique for measuring exhaled NO.8 The mean exhaled
NO value was the average peak value over 10 breaths.
After a 30-minute equilibration period, baseline hemody-
namic measurements and arterial blood samples were
obtained. The inhaled FIO2 was decreased to 12% to induce
hypoxia, resulting in a systemic saturation of 65% to 70%.
Hemodynamic measurements and arterial blood samples
were taken at 5, 15, 30, 45, 60, 75, and 90 minutes of hypox-
ia. Animals were administered fluid boluses of 5 to 10 mL/kg
of 0.9% sodium chloride as needed to maintain a mean arte-
rial pressure above 35 mm Hg, with a volume limit of 40
mL/kg. Sodium bicarbonate was given, if needed, to maintain
blood pH above 7.3. The ventilator rate was adjusted to main-
tain the PCO2 between 38 and 42 mm Hg. The tidal volume
remained at 18 ± 1 mL/kg to ensure that changes in pul-
monary mechanics accurately reflected alterations in the
lungs and were not caused by ventilator manipulation.
After 90 minutes of hypoxia, animals were placed on car-
diopulmonary bypass (CPB) with a bypass circuit PO2 greater
than 450 mm Hg. CPB was incorporated to simulate a newborn
undergoing repair of congenital heart defects. Arterial cannula-
tion was through the right carotid artery, and venous cannula-
tion was through the right atrial appendage. The ventilator FIO2
was increased to 100% during CPB, and the rate decreased to 4
breaths per minute to prevent atelectasis. Animals were not
actively cooled and were not allowed to drift below a rectal
body temperature of 32°C to minimize the effects of hypother-
mia. Flow rates on CPB were maintained at 100 mL · kg–1 ·
min–1, with a minimum mean arterial pressure of 35 mm Hg.
After 1 hour of CPB, animals were warmed to 38°C,
weaned from CPB, and returned to normoxic conditions (FIO2
= 40%). The animals were maintained under similar condi-
tions as baseline for 2 hours. Blood samples were obtained
for the measurement of aortic and pulmonary arterial nitrite,
and exhaled NO and hemodynamics were recorded at 15, 30,
60, and 120 minutes of recovery.
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An additional 5 animals (group II) were instrumented,
maintained at normoxia (FIO2 = 40%) for 90 minutes, placed
on CPB for 1 hour, and allowed to recover for an additional 2
hours. These animals served as controls to demonstrate any
changes from CPB alone. Other investigators have confirmed
the minimal effect of bypass in similar models.9
Tissue myeloperoxidase assay. Frozen lung samples col-
lected at baseline, end hypoxia, and end recovery were
homogenized in 1 mL of a solution containing 0.5% hexade-
cyltrimethyl-ammonium bromide dissolved in 10 mmol/L 3-
[N-morpholino]propanesulfonic acids and then centrifuged at
21,000g for 20 minutes at 4°C. The supernatant (100 µL) was
mixed with 700 µL of sodium phosphate (80 mmol/L, pH
5.5) and 100 µL of tetramethyl benimide (16 mmol/L) and
incubated at 25°C for 5 minutes. Then 100 µL of 1 mmol/L
hydrogen peroxide was added and incubated for exactly 3
minutes at 25°C. A blank without hydrogen peroxide was
also analyzed for each tissue. The reaction was stopped by
the addition of 1 mL of cold acetic acid (2 mol/L). The opti-
cal density was measured at 650 nm on a spectrophotometer
(Labsystems Multiscan MCC/340, Franklin, Mass).
Myeloperoxidase (MPO) activity was expressed as units per
50 mg of tissue per 3 minutes. MPO activity is representative
of leukocyte activity in the tissue.
Tissue lipid peroxidase assay. Frozen lung tissue was
homogenized in 10 volumes (1 mL/100 mg) of 10% (vol/vol)
1.15% potassium chloride on ice. A modified thiobarbituric
acid reaction technique was used. The optical density at 532
nm was measured, and concentration was determined by
using a Spectronic Genesys spectrophotometer (Spectronic
Instruments, Rochester, NY). Concentrations were calculated
with the use of standard solutions of malondialdehyde-
dimethylacetate (0.5-16 nmol) and expressed as nanomoles
per 100 mg of wet tissue. Tissue lipid peroxidase measure-
ments are an indication of membrane peroxidation, a marker
of free radical–mediated injury.
Nitrite assay. Blood levels of NO were estimated by mea-
surement of aortic and pulmonary arterial nitrate and nitrite
by using a 2-part assay converting nitrate to nitrite by the
Griess reaction.10,11 The optical density of each well was read
at 550 nm, with correction at 650 nm (Labsystems Multiscan
MCC/340). The data were analyzed by using GENESIS soft-
ware (Fisher Scientific Co, Pittsburgh, Pa), and total nitrite
levels (in micromoles per liter) were reported. Pulmonary
arterial nitrite values were not obtained from 2 animals, and
values from 2 other animals were several SDs from the mean
and were excluded secondary to presumed collection or pro-
cessing error. Hence, pulmonary arterial nitrite values are
reported from 6 animals compared with 10 animals for the
aortic nitrite values.
Statistical analysis. Data were reported as the mean ± SD.
Analysis of variance and the 2-tailed paired Student t test
were used to compare values at different time points. A P
value of less than or equal to .05 was considered significant
(Statview 4.01 software; Abacus Concepts Inc, Berkeley,
Calif).
Results
Animals demonstrated a general descending trend in
hemodynamics during hypoxia, with only partial
recovery after reoxygenation (Table I). Cardiac output
dropped by as much as 40% by end hypoxia and was
only 72% of prehypoxia values at end recovery.
Oxygen delivery at end recovery was 57% of baseline.
Cardiac output and oxygen delivery in group II animals
were not different from baseline at end recovery (91%
and 84%, respectively).
Pulmonary vascular resistance (PVR) increased
promptly with the onset of hypoxia in all group I ani-
mals (Fig 1). PVR increased 515% by end hypoxia (P
= .005) from a baseline of 66 ± 14 to 340 ± 42 dynes ·
s–1 · cm–5. PVR decreased after reoxygenation on CPB
but did not return to baseline by end recovery (146 ± 21
dynes · s–1 · cm–5, 221% of baseline; P = .04). In con-
junction with the rise in PVR, both aortic and pul-
monary arterial nitrite decreased. Aortic nitrite
decreased to less than one half of the baseline value
(102 ± 13 vs 49 ± 7 µmol/L, P = .05) but returned to
baseline by end recovery (96 ± 8 µmol/L, P > .2)
despite the persistence of significantly elevated PVR.
Pulmonary arterial nitrite had a similar but less pro-
nounced decrease during hypoxia and return to base-
line after reoxygenation (Fig 1). In group II PVR
remained unchanged before CPB and increased by no
more than 25% in any animal after CPB and recovery
(78 ± 15 dynes · s–1 · cm–5 at baseline vs 96 ± 14 dynes
· s–1 · cm–5 at end recovery).
Baseline mean exhaled NO in group I was 34 ± 14
ppb and remained stable during baseline normoxia.
During hypoxia, exhaled NO decreased to 35% of
baseline by end hypoxia (12 ± 9 ppb, P = .005; Fig 1).
The 70% decrease in exhaled NO was associated with
a 54% decrease in aortic nitrite levels and a 27%
decrease in pulmonary arterial nitrite levels. However,
unlike aortic and pulmonary arterial nitrite levels that
returned to baseline levels after reoxygenation, exhaled
NO decreased further despite the restoration of nor-
moxic conditions (7 ± 6 ppb at end recovery, P = .005
compared with baseline; Fig 1). In group II exhaled NO
was not different from baseline at end recovery (26 ± 9
vs 25 ± 8 ppb, P > .2).
Impairment in exhaled NO production was associat-
ed with alterations in pulmonary function and mechan-
ics. Dynamic pulmonary compliance decreased signif-
icantly from 6.6 ± 0.9 mL/cm H2O at baseline to 5.0 ±
0.7 mL/cm H2O at end hypoxia and 5.4 mL/cm H2O at
end recovery (P = .05 compared with baseline; Fig 2).
Concomitant with the decrease in Cdyn, RaW
increased over baseline during hypoxia and reoxygena-
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tion (41 ± 4 cm of H2O · L–1 · s–1 at baseline, 56 ± 4.9
cm H2O · L–1 · s–1 at end hypoxia, and 50 ± 5 cm H2O
· L–1 · s–1 at end recovery; Fig 2). Gas exchange in
group I, as determined by alveolar-arterial gradient,
was significantly lower after reoxygenation than at
baseline (84 vs 32 mm Hg, P = .005). In contrast, the
alveolar-arterial gradient was only slightly above the
baseline level in group II animals after CPB (41 vs 53
mm Hg, P = .11). RaW and Cdyn were not significant-
ly changed from baseline at end recovery in group II
(Table I).
Concurrent with the impaired pulmonary mechan-
ics and decreased exhaled NO after reoxygenation
there was an increase in leukocyte-mediated injury,
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Table I. Cardiopulmonary, exhaled nitric oxide, and vascular nitrite data during hypoxia or normoxia and recovery
in neonatal pigs
CPB controls* P value versus Hypoxia/reoxygenation† P value versus P value versus 
(group II, n = 5) baseline (group I, n = 10) baseline control
PVR (dynes · s–1 · cm–5)
Baseline 78 ± 15 66 ± 14 >.2
Hypoxia or normoxia (15 min) 85 ± 13 >.2 260 ± 20 .01 .005
Hypoxia or normoxia (90 min) 85 ± 13 >.2 340 ± 42 .01 .005
Recovery (60 min) 101 ± 16 >.2 138 ± 25 .05 .06
Recovery (120 min) 96 ± 14 >.2 146 ± 21 .04 .05
RaW (cm H2O · L–1 · s–1)
Baseline 40 ± 4.2 41 ± 4.0 >.2
Hypoxia or normoxia (15 min) 41 ± 3.8 >.2 48 ± 5.1 .05 .05
Hypoxia or normoxia (90 min) 42 ± 4.3 >.2 56 ± 4.9 .03 .04
Recovery (60 min) 44 ± 4.1 >.2 48 ± 4.9 .05 .06
Recovery (120 min) 41 ± 3.8 >.2 50 ± 5.0 .04 .03
Cdyn (mL/cm H2O)
Baseline 6.8 ± 0.6 >.2 6.6 ± 0.9 >.2
Hypoxia or normoxia (15 min) 6.9 ± 0.5 >.2 6.3 ± 0.9 .07 .06
Hypoxia or normoxia (90 min) 6.8 ± 0.7 >.2 5.0 ± 0.7 .05 .03
Recovery (60 min) 6.3 ± 0.5 .1 5.3 ± 1.0 .05 .05
Recovery (120 min) 6.5 ± 0.7 .1 5.4 ± 0.7 .05 .05
Cardiac output (mL/min)
Baseline 775 ± 80 824 ± 72 >.2
Hypoxia or normoxia (15 min) 790 ± 74 >.2 730 ± 76 .08 >.2
Hypoxia or normoxia (90 min) 792 ± 71 >.2 490 ± 56 .02 .03
Recovery (60 min) 712 ± 78 >.2 641 ± 60 .05 .09
Recovery (120 min) 748 ± 64 >.2 590 ± 69 .04 .04
Exhaled NO (ppb)
Baseline 29 ± 6 34 ± 14 >.2
Hypoxia or normoxia (15 min) 27 ± 8 >.2 25 ± 11 .05 >.2
Hypoxia or normoxia (90 min) 28 ± 9 >.2 12 ± 9 .01 .008
Recovery (60 min) 24 ± 7 >.2 9 ± 6 .01 .008
Recovery (120 min) 25 ± 8 >.2 7 ± 6 .01 .01
Aortic nitrite (µmol/L)
Baseline 94 ± 8 102 ± 13 >.2
Hypoxia or normoxia (15 min) 97 ± 5 >.2 74 ± 7 .06 .07
Hypoxia or normoxia (90 min) 92 ± 7 >.2 49 ± 7 .05 .05
Recovery (60 min) 86 ± 11 >.2 75 ± 10 .07 .1
Recovery (120 min) 95 ± 9 >.2 96 ± 8 >.2 >.2
Pulmonary arterial nitrite (µmol/L) n = 6
Baseline 31 ± 8
Hypoxia or normoxia (15 min) 35 ± 9 .06
Hypoxia or normoxia (90 min) 23 ± 3 .04
Recovery (60 min) 50 ± 13 .16
Recovery (120 min) 41 ± 5 >.2
Values are means ± SD.
*CPB controls indicates animals subjected to 90 minutes of normoxia followed by 1 hour of reoxygenation on CPB and 2 hours of normoxic recovery.
†Hypoxia/reoxygenation indicates animals subjected to 90 minutes of hypoxia followed by 1 hour of reoxygenation on CPB and 2 hours of normoxic recovery.
as demonstrated by a marked increase in pulmonary
MPO activity (Fig 3). Pulmonary lipid peroxidase
(LPO) levels were also significantly increased after
reoxygenation (6.68 ± 0.98 nmol/100 mg of wet tis-
sue at baseline vs 8.26 ± 1.06 nmol/100 mg of wet
tissue at end recovery, P = .008; Fig 3). CPB alone
did not result in significant increases in pulmonary
MPO activity or LPO levels. MPO activity increased
only slightly from 0.18 ± 0.06 U/50 mg of wet tissue
at baseline to 0.24 ± 0.08 U/50 mg of wet tissue at
end recovery in group II (P = .2). LPO values were
6.52 ± 0.79 nmol/100 mg of wet tissue at baseline
compared with 6.78 ± 0.86 nmol/100 mg of wet tis-
sue at end recovery in group II (P > .2).
Discussion
Recent evidence indicates that altered exhaled NO
levels are associated with various pathologic condi-
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Fig 1. A comparison of changes in PVR with arterial nitrite
and exhaled nitric oxide in groups I and II. Top, Aortic and
pulmonary arterial nitrite levels in group I decreased at end
hypoxia and returned to baseline levels by end recovery.
Center, PVR increased in group I by 15 minutes of hypoxia,
remained elevated during hypoxia, and then returned almost
to baseline by end recovery. Bottom, Exhaled nitric oxide lev-
els decreased below baseline levels by end hypoxia and
remained lower through recovery, suggesting bronchial
epithelial injury. PVR, nitrite, and exhaled nitric oxide levels
in group II did not change throughout hypoxia and recovery.
P values are group I versus group II, as determined by using
analysis of variance. Hyp/Nor, Hypoxia (group I) or normox-
ia (group II); PA, pulmonary artery.
Fig 2. A comparison of changes in inspiratory airway resis-
tance and dynamic airway compliance with exhaled nitric
oxide in groups I and II. Top, Inspiratory airway resistance
increased during hypoxia in group I and remained elevated
after reoxygenation. Center, Dynamic airway compliance in
group I decreased during hypoxia and remained depressed
after reoxygenation despite a return to normoxia. Bottom,
The decrease in airway resistance and dynamic airway com-
pliance in group I was associated with decreased exhaled
nitric oxide at end hypoxia and throughout recovery. Airway
resistance and dynamic airway compliance did not change in
group II throughout hypoxia and recovery. P values are group
I versus group II, as determined by using analysis of variance.
Hyp/Nor, Hypoxia (group I) or normoxia (group II).
tions, such as adult respiratory distress syndrome, asth-
ma, congestive heart failure, and endotoxemia.3,12-15
Each of these conditions demonstrates changes in PVR
and mechanics. Fluctuations in exhaled NO in these
various pathologic states might be a useful marker of
acute lung injury.16
The current study demonstrated that marked decreas-
es in exhaled NO were associated with changes in pul-
monary mechanics and increased MPO and LPO in
pigs subjected to hypoxia and subsequent reoxygena-
tion on CPB. In addition, to test whether changes in
exhaled NO correspond to decreased pulmonary vascu-
lar or systemic NO production, both aortic and pul-
monary arterial nitrite levels were measured as an esti-
mate of NO production. No association was found
between aortic or pulmonary arterial nitrite levels and
exhaled NO after reoxygenation.
Our findings supported the proposed concept that
exhaled NO correlates poorly with plasma nitrite lev-
els.17,18 There was a persistent decline in exhaled NO
after reoxygenation, whereas both aortic and pul-
monary arterial nitrite measurements returned to base-
line levels. The significance of exhaled NO and the
relationship to plasma nitrite levels remains controver-
sial. One explanation for the divergence in exhaled NO
and plasma nitrite levels is that exhaled NO reflects air-
way NO production generated by NOS II, which is
constitutively expressed in bronchial epithelium,19
whereas plasma nitrite presumably reflects NO pro-
duced either from the pulmonary endothelium, sys-
temic NO production, or both. In support of this con-
cept is the fact that hemoglobin binds NO with high
affinity and reduces it to nitrate and nitrate, thereby
curtailing the crossing of pulmonary arterial NO into
the bronchial tree.17,18
Acute pulmonary injury from hypoxia-reoxygenation
might adversely affect bronchial NOS II activity,
whereas vascular NOS, which is derived from many
sources in the body, might not be affected to the same
degree. The decrease in both aortic and pulmonary
arterial nitrite during hypoxia was associated with
decreases in exhaled NO. This is consistent with what
is known regarding the effect of hypoxia on NOS activ-
ity. However, once normoxic condition returned, both
pulmonary arterial and aortic nitrite levels increased
back to baseline values, suggesting recovery of pul-
monary endothelial NOS activity and NO production.
In contrast, exhaled NO remained depressed, actually
decreasing further after reoxygenation. Because NO
produced by vascular endothelium is rapidly reduced
by hemoglobin rather than readily passing into the
alveolus, we believe that the changes occurring in
exhaled NO represented a distinct process.17,18 Studies
are currently underway to look specifically at bronchial
NOS II activity compared with pulmonary NOS activ-
ity in this model.
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Fig 3. LPO levels and MPO activity in lung tissue from group I animals during hypoxia and recovery. A, Lipid
peroxidase levels were increased at end recovery, indicating lipid peroxidation and oxidative stress in lung tissue
from group I animals. B, Pulmonary MPO activity, a marker of leukocyte activity, was elevated in the lung tissue
collected from group I animals at end recovery, suggesting that reoxygenation resulted in leukocyte-mediated
injury.
Although measurement of plasma nitrite and nitrate is
an accepted method of estimating blood levels of NO,
this method somewhat limits the attempts to compare
changes in exhaled NO with blood NO levels. Inferences
from nitrite measurements must be viewed cautiously
because nitrite measurements are only a marker of NO
levels. The lack of an easily applied in vivo method to
directly measure NO levels in the blood is a limiting fac-
tor in studies looking at in vivo NO changes.
Furthermore, because of the longer half-life of nitrite
compared with NO itself and because of the difference in
sample number for the pulmonary arterial and aortic
nitrite values, no conclusions can be inferred from
attempts to determine a transpulmonary gradient of
nitrite. However, the postreoxygenation increase in both
pulmonary arterial and aortic nitrite compared with the
continued decline of exhaled NO does appear significant.
In our model the dual insults of hypoxia and subse-
quent reoxygenation on CPB resulted in more pro-
nounced acute lung injury than CPB alone, which result-
ed in trivial alterations in pulmonary mechanics and
PVR and no change in exhaled NO. There is significant
variation, especially in animal studies, regarding the
effect of CPB on pulmonary function. However, the
absence of significant injury after CPB alone in our
model is supported both by other animal studies20,21 and
clinical experience in which patients are commonly
extubated within 12 hours of surgery with minimal pul-
monary changes. The use of an identical bypass circuit
and oxygenator to those used clinically in our institution,
the lack of significant cooling, the use of proper donor
blood handling and storage, and the participation of a
clinical perfusionist minimized the effect of CPB in our
model and provided a clinically relevant and consistent
method of reoxygenation. It has been suggested that
CPB alone might decrease exhaled NO levels. Beghetti
and colleagues22 demonstrated a modest decrease in
exhaled NO from children undergoing CPB. However,
inhalational anesthetics that are known to decrease
exhaled NO are often used in clinical settings and might
contribute to a decrease in exhaled NO production. In
the current study exhaled NO levels did not change dur-
ing or after CPB in the control animals.
Baseline exhaled NO levels in the current study were
within the range of 20 to 35 ppb, which was previous-
ly measured in human beings and animals.12,23 With the
onset of hypoxia, exhaled NO progressively decreased
with reduced inspired oxygen. This was consistent with
the findings of Nelin and associates,12 who demon-
strated decreased exhaled NO during hypoxia in an iso-
lated piglet lung model. A similar decrease in exhaled
NO was also seen when the NOS inhibitor N-nitro-L-
arginine methyl ester (L-NAME) was administered to
normoxic control lungs. Other researchers have shown
a similar, although more modest, decrease in exhaled
NO with moderate hypoxia and a more marked
decrease when FIO2 was below 5%. The rapid decrease
in exhaled NO associated with hypoxia might be a
direct inhibitory effect of inspired FIO2 (alveolar PO2)
or pulmonary arterial PO2 on NOS II activity.24 In con-
trast, the continued decrease in exhaled NO detected
during reoxygenation and recovery might be due to
bronchial epithelial injury.
Decreased exhaled NO levels have been associated
with altered pulmonary mechanics in numerous patho-
logic conditions.4,12-14 Changes in exhaled NO might
be a marker of airway disease and injury, as well as an
indicator of the effectiveness of therapy. In this study
decreased exhaled NO was associated with decreased
pulmonary compliance and increased airway resistance
despite a fixed tidal volume.
A unifying explanation of the data is that hypoxia-
reoxygenation injury resulted in bronchial epithelial
injury and dysfunction, led to decreased exhaled NO
production, and contributed to altered airway resistance
and pulmonary compliance. Increased MPO activity
and LPO levels after reoxygenation implied that leuko-
cyte-mediated reoxygenation injury occurred. It was
notable that animals subjected to CPB without preced-
ing hypoxia did not have increased MPO activity or
LPO levels. It is likely that reoxygenation injury was
not limited to the bronchial epithelium and that other
areas of the lung, such as the pulmonary vascular
endothelium, might also have been affected.
This study demonstrated that decreased exhaled NO
was associated with altered pulmonary mechanics dur-
ing hypoxia. Furthermore, there was a poor association
between plasma nitrite levels and exhaled NO, suggest-
ing two distinct entities. After reoxygenation, exhaled
NO levels remained depressed, possibly indicating
bronchial epithelial injury. Bronchial epithelial dys-
function and decreased bronchial NO production might
contribute to the persistent changes in pulmonary
mechanics detected after hypoxia and reoxygenation.
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